The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index; 69 of the 118 sources its claims cite were checked for support.
Exposure to Per- and Polyfluoroalkyl Substances (PFASs) in Healthcare: Environmental and Clinical Insights
Open accessAbstract
Per- and polyfluoroalkyl substances (PFASs) are synthetic chemicals extensively used in various industries due to their unique physicochemical properties. Their persistence in the environment and potential for bioaccumulation have raised significant health concerns. This review aims to elucidate the sources, exposure pathways, toxicological effects, and regulatory measures related to PFASs, with a particular focus on pediatric populations and medical applications. A comprehensive narrative review was conducted using PubMed, Scopus, and Web of Science to identify peer-reviewed literature published between 2000 and 2025. The search focused on PFAS use in healthcare, environmental contamination, exposure pathways, health effects, and regulatory actions. Relevant studies, reports, and policy documents were screened and thematically synthesized by the authors to evaluate clinical and environmental risks, particularly in pediatric populations. PFAS exposure is linked to various adverse health effects, including immunotoxicity, endocrine disruption, metabolic disorders, and carcinogenicity. Children are particularly vulnerable due to developmental susceptibilities and exposure through medical devices and environmental sources. Regulatory measures are evolving, but gaps remain, especially concerning medical device applications. There is an urgent need for comprehensive strategies to monitor and mitigate PFAS exposure, particularly in vulnerable populations. Enhanced regulatory frameworks, safer alternatives in medical devices, and public health interventions are essential to address the challenges posed by PFASs.
Overview
CoChat Summary
TL;DR
This narrative review synthesizes evidence that PFAS exposure occurs through both environmental contamination and healthcare-related pathways, with children and intensive-care patients especially vulnerable. It highlights persistent toxicological risks—immunotoxicity, endocrine disruption, metabolic disease, and carcinogenicity—while noting major gaps in quantifying PFAS leaching from medical devices and regulating PFAS in medical products.
Key findings
- Environmental contamination is widespread: a 2024 global survey of >45,000 surface and groundwater samples found ~31% exceeded PFAS thresholds harmful to human health; PFASs were detected in 45% of surveyed North American tap water sources, and the U.S. EPA indicated 70 million Americans receive drinking water with detectable PFASs. In Canada, nearly 69% of groundwater samples in regulated regions surpassed national PFAS thresholds, and biosolid-amended soils reached PFAS levels as high as 300 µg/kg.
- Pediatric exposure is elevated: the CHARGE study reported median PFOS serum levels of 8.1 ng/mL (range 5.0–31.5) in children aged 2–5, exceeding maternal levels; Norwegian cohort data found about 20% of children under 12 exceeded current safety thresholds; a PBPK model estimated mean PFOS 7–12 ng/mL and PFOA 3–6 ng/mL in children aged 6–12.
- Health effects include immunotoxicity, endocrine disruption, metabolic disruption, neurodevelopmental harm, and cancer: IARC Monograph 135 (2023) classifies PFOA as Group 1 and PFOS as Group 2B; prenatal PFOS, PFOA, and PFHxS were linked to 1.6–2.0 point reductions in boys’ performance IQ per log-unit increase; PFAS exposure was associated with reduced birth weight (up to 181 g per ng/mL increase in PFHpS).
- Regulatory action is advancing but incomplete: the EU Drinking Water Directive sets 0.1 µg/L for the sum of 20 PFASs and 0.5 µg/L for total PFASs by January 12, 2026; the U.S. EPA set MCLs of 4 ppt for PFOA and PFOS and a cumulative hazard index of 1.0 for PFNA, PFHxS, PFBS, and GenX. However, specific regulations for PFASs in medical devices remain limited, and direct patient exposure from devices such as ECMO circuits and ICU tubing is largely unquantified.
Methods
- Narrative review designed to synthesize evidence on PFAS exposure through environmental pathways relevant to child health and healthcare settings, particularly PICUs, NICUs, and general pediatric departments.
- Literature search across PubMed, Scopus, and Web of Science for peer-reviewed publications from January 2000 to March 2025, plus gray literature from ECHA, U.S. EPA, and WHO; English-language publications only.
- PRISMA-style screening: 2345 records retrieved, 422 duplicates removed, 1923 title/abstract screened, 1612 excluded, 311 full-text reviewed, and 152 publications included in a final qualitative synthesis organized into thematic sections.
Limitations
- The paper states that direct measurement of PFAS exposure in patients on ECMO has not yet been reported, quantitative assessments of PFAS leaching from ICU tubing and other in-hospital devices are absent, and clinical exposure via medical devices remains largely unquantified.
- The paper notes that proposed short-chain PFAS substitutes such as GenX remain under-investigated and may carry similar risks, and that regulatory frameworks are inconsistent and incomplete, especially for medical devices.
- Evident from the text: as a narrative review with qualitative synthesis, it does not pool effect estimates or formally assess risk of bias; inclusion was limited to English-language literature and gray literature from selected agencies, which may introduce selection and language bias.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
46 Valid · 10 Not valid · 33 Not checked · 15 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Biomonitoring data show that young children frequently have higher serum PFAS concentrations than adults, particularly in environmentally contaminated areas [5,42,43,60].”
§ Exposure to Per- and Polyfluoroalkyl Substances (PFASs) in Healthcare: Environmental and Clinical Insights > 4. Environmental Contamination and Residential Exposure > 4.3. Vulnerability in Pediatric Populations
What the sources say
- Not checked — no full text of the sourcecites [5] Kim, 2014, Perfluorinated Compounds in Serum and Urine Samples from Children Aged 5-13 Years in South Korea, Environ. Pollut. source
- Not checked — no full text of the sourcecites [42] Wen, 2014, Field Study on the Uptake and Translocation of Perfluoroalkyl Acids (PFAAs) by Wheat (Triticum aestivum L.) Grown in Biosolids-Amended Soils, Environ. Pollut. source
- Could not verifycites [43] Fraser, 2012, Polyfluorinated Compounds in Serum Linked to Indoor Air in Office Environments, Environ. Sci. Technol. sourceExperimental — accuracy not yet measured
The Results (Serum Concentrations; page unavailable) report PFAS measurements in office workers, while the Discussion (page unavailable) compares those measurements with U.S. general-population trends. Neither passage compares young children with adults or addresses environmentally contaminated areas. Searches for child–adult serum comparisons and contaminated areas found no passage making the claimed point. (LLM, conf=0.76)
- Disputedcites [60] Minucci, 2024, Linking Exposure to Per- and Polyfluoroalkyl Substances (PFAS) in House Dust and Biomonitoring Data in Eight Impacted Communities, Environ. Int. sourceExperimental — accuracy not yet measured
The Results section (‘Relationship between PFAS levels in serum and house dust’; page unavailable) reports the opposite age pattern: older participants had higher overall serum PFAS levels in the eight impacted communities. The Methods section (‘Statistical analysis’; page unavailable) also notes that older individuals have been found to have higher serum PFAS in several populations. (LLM, conf=0.89)
Checked by a reasoning model — may be wrong.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Furthermore, current regulatory frameworks are inconsistent and incomplete, particularly regarding cumulative exposure risks and long-term environmental impacts [12].”
§ Exposure to Per- and Polyfluoroalkyl Substances (PFASs) in Healthcare: Environmental and Clinical Insights > 1. Introduction
What the sources say
- Supportedcites [12] Kwiatkowski, 2020, Scientific Basis for Managing PFAS as a Chemical Class, Environ. Sci. Technol. Lett. source
In “Regulatory Approaches” (page unavailable), the paper describes differing PFAS regulatory approaches and says regulating small subgroups ignores most PFAS and underestimates overall risk. “Health and Environmental Hazards” describes limited, varying treatment of combined exposures; “Environmental Exposure: Persistence, Accumulation, and Mobility” explains the long-term accumulation and harm that the paper argues more comprehensive management must address. (LLM, conf=0.86)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A comprehensive global survey published in 2024 analyzed over 45,000 surface and groundwater samples and found that approximately 31% of samples exceeded PFAS thresholds deemed harmful to human health [35].”
§ Exposure to Per- and Polyfluoroalkyl Substances (PFASs) in Healthcare: Environmental and Clinical Insights > 4. Environmental Contamination and Residential Exposure > 4.1. Environmental Sources and Pathways of Exposure
What the sources say
- Partly supportedcites [35] Gilbert, 2024, Underestimated Burden of Per- and Polyfluoroalkyl Substances in Global Surface Waters and Groundwaters, Nat. Geosci. sourceExperimental — accuracy not yet measured
The Methods report 48,985 samples, supporting the claim that the study analyzed over 45,000 surface and groundwater samples. In “Extent of global PFAS water contamination,” however, 31% refers specifically to groundwater samples with no known contamination source exceeding the proposed US EPA hazard-index drinking-water criterion—not to approximately 31% of all samples exceeding PFAS thresholds generally. The paper says exceedance rates vary by threshold and contamination source. (LLM, conf=0.92)
plainn = 45,000- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Studies have shown that trace amounts of PFASs can migrate from polymer coatings or plastic components into fluids administered intravenously or via enteral feeding, raising potential toxicological and bioaccumulation risks [5,34].”
§ Exposure to Per- and Polyfluoroalkyl Substances (PFASs) in Healthcare: Environmental and Clinical Insights > 3. PFAS in Medical Applications > 3.4. Concerns About PFASs Leaching and Exposure
What the sources say
- Not checked — no full text of the sourcecites [5] Kim, 2014, Perfluorinated Compounds in Serum and Urine Samples from Children Aged 5-13 Years in South Korea, Environ. Pollut. source
- Partly supportedcites [34] Vuong, 2021, Childhood Exposure to Per- and Polyfluoroalkyl Substances (PFAS) and Neurobehavioral Domains in Children at Age 8 Years, Neurotoxicol Teratol. sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) describes PFAS as persistent chemicals detected in human tissues and links them to health concerns. It does not address migration from polymer coatings or plastic components into intravenous or enteral fluids; searches for those routes found no supporting passage. The Results (page unavailable) report childhood PFAS body burdens, but not bioaccumulation from medical fluids. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Their inert surfaces reduce hemolysis and thrombogenicity [19].”
§ Exposure to Per- and Polyfluoroalkyl Substances (PFASs) in Healthcare: Environmental and Clinical Insights > 3. PFAS in Medical Applications > 3.1. Essential Roles in Medical Devices
What the sources say
- Could not verifycites [19] Jayanthy, 2024, Polyfluoroalkyl-Substances Detection in Junk Food Packing Materials Using Various Analytical Methods: A Review, Cureus sourceExperimental — accuracy not yet measured
The Introduction and background discusses PFAS resistance and uses in food packaging, while the Review addresses PFAS detection and health risks; neither section addresses blood-contact devices. Searches for hemolysis, thrombogenicity, and blood-contacting devices found no passage supporting the claimed reduction. (LLM, conf=0.75)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
50 more claims · 25 with their cited sources checked
Create a free account to see all 104 claims and to verify the 2 references still open.
- It may state two separate claims as one. 43
- Probably not a substantial claim. 13
Citations
Cites
Buck, R. C., Franklin, J., Berger, U., Conder, J. M., Cousins, I. T., de Voogt, P., Jensen, A. A., Kannan, K., Mabury, S. A., & van Leeuwen, S. P. (2011) · Integrated Environmental Assessment and Management · doi:10.1002/ieam.258 · Cited by 4,641 · cited 2×
“Such characteristics make PFASs nearly indispensable in the manufacture, performance, and safety of various medical devices and diagnostic tools [1,2,12].”
Sunderland, E. M., Hu, X. C., Dassuncao, C., Tokranov, A. K., Wagner, C. C., & Allen, J. G. (2019) · Journal of Exposure Science & Environmental Epidemiology · doi:10.1038/s41370-018-0094-1 · Cited by 2,786
Global Distribution of Perfluorooctane Sulfonate in Wildlife
Giesy, J. P., & Kannan, K. (2001) · Environmental Science & Technology · doi:10.1021/es001834k · Cited by 2,750
An overview of the uses of per- and polyfluoroalkyl substances (PFAS)
Glüge, J., Scheringer, M., Cousins, I. T., DeWitt, J. C., Goldenman, G., Herzke, D., Lohmann, R., Ng, C. A., Trier, X., & Wang, Z. (2020) · Environmental Science: Processes & Impacts · doi:10.1039/d0em00291g · Cited by 2,466
A Never-Ending Story of Per- and Polyfluoroalkyl Substances (PFASs)?
Wang, Z., DeWitt, J. C., Higgins, C. P., & Cousins, I. T. (2017) · Environmental Science & Technology · doi:10.1021/acs.est.6b04806 · Cited by 1,921
Biomaterials: Where We Have Been and Where We Are Going
Ratner, B. D., & Bryant, S. J. (2004) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.6.040803.140027 · Cited by 1,507
Kurwadkar, S., Dane, J., Kanel, S. R., Nadagouda, M. N., Cawdrey, R. W., Ambade, B., Struckhoff, G. C., & Wilkin, R. (2022) · Science of The Total Environment · doi:10.1016/j.scitotenv.2021.151003 · Cited by 937
Serum Vaccine Antibody Concentrations in Children Exposed to Perfluorinated Compounds
Grandjean, P., Andersen, E. W., Budtz-Jørgensen, E., Nielsen, F., Mølbak, K., Weihe, P., & Heilmann, C. (2012) · JAMA · doi:10.1001/jama.2011.2034 · Cited by 809
Scientific Basis for Managing PFAS as a Chemical Class
Kwiatkowski, C. F., Andrews, D. Q., Birnbaum, L. S., Bruton, T. A., DeWitt, J. C., Knappe, D. R. U., Maffini, M. V., Miller, M. F., Pelch, K. E., Reade, A., et al. (2020) · Environmental Science & Technology Letters · doi:10.1021/acs.estlett.0c00255 · Cited by 721 · cited 4×
“Furthermore, current regulatory frameworks are inconsistent and incomplete, particularly regarding cumulative exposure risks and long-term environmental impacts [12].”
InfluentialAccumulation of perfluorinated alkyl substances (PFAS) in agricultural plants: A review
Ghisi, R., Vamerali, T., & Manzetti, S. (2019) · Environmental Research · doi:10.1016/j.envres.2018.10.023 · Cited by 705
Research works printed but not linked: 3
- Brandsch, 2022, Determination of PFAS in Water According to EU 2020/2184 and DIN 38407-42 Using Online SPE–LC–MS/MS, MJH Life Sci., 18, 8
- National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Division on Earth and Life Studies, Board on Population Health and Public Health Practice, Board on Environmental Studies and Toxicology, and Committee on the Guidance on PFAS Testing and Health Outcomes (2022). Guidance on PFAS Exposure, Testing, and Clinical Follow-Up, National Academies Press (US). The National Academies Collection: Reports Funded by National Institutes of Health.
- IARC Working Group on the Identification of Carcinogenic Hazards to Humans (2025, June 19). Perfluorooctanoic Acid (PFOA) and Perfluorooctanesulfonic Acid (PFOS), Available online: http://www.ncbi.nlm.nih.gov/books/NBK614282/.
Cited by
Dobrzyńska, E., Wasilewski, P., & Pośniak, M. (2025) · Applied Sciences · doi:10.3390/app152211884 · Cited by 36
From environment to organs: individual and combined effects of MPs and PFAS on urinary system health
Li, D., Wang, T., Zhang, W., Li, M., Du, W., & Wang, J. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1782952 · Cited by 2
Evaluation of the reproductive toxicity of endocrine disruptors during early embryo development
Parra-Forero, L. Y., & Nowak, R. A. (2026) · Biology of Reproduction · doi:10.1093/biolre/ioag154
Dimri, S., Bisht, B., Vlaskin, M., Kurbatova, A., Jaiswal, K. K., Rajput, V. S., Sharma, R., Chauhan, P. K., & Kumar, V. (2025) · Food and Humanity · doi:10.1016/j.foohum.2025.100982
Awoyemi, O. S., & Naidu, R. (2026) · Chemosphere · doi:10.1016/j.chemosphere.2026.144981 · Cited by 1
Metadata
- Authors
- Briassoulis, G., Ilia, S., & Briassouli, E.
- Affiliations
- University of Crete (GR)
- National and Kapodistrian University of Athens (GR)
- Corresponding author
- Briassoulis, George
- Venue
- Life
- Publisher
- MDPI AG
- Published
- 2025-07-01
- Volume
- 15
- Issue
- 7
- Pages
- 1057
- ISSN
- 2075-1729 (ISSN-L)
- PMC
- PMC12298592
- OpenAlex
- W4411887479
- Semantic Scholar
- ad166308097d78bba8cdb5a4b77832f943ff6eaa
- Cited by
- 15
- References
- 126
- Citations by year
- 2026: 13 · 2025: 2
- FWCI
- 1.15
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Life (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Physical Sciences › Environmental Science › Environmental Chemistry › Per- and polyfluoroalkyl substances research
- Physical Sciences › Materials Science › Polymers and Plastics › Synthesis and properties of polymers
- Physical Sciences › Chemistry › Organic Chemistry › Fluorine in Organic Chemistry
- Keywords
- per- and polyfluoroalkyl substances, PFAS exposure, health care, medical devices, children's exposure, immunotoxicity, endocrine disruption, carcinogenicity, metabolic disorders, environmental contamination, exposure pathways, PFAS regulation, safer alternatives, bioaccumulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Exposure to Per- and Polyfluoroalkyl Substances (PFASs) in Healthcare: Environmental and Clinical Insights. https://app.cochat.ai/papers/10.3390/life15071057
- The paper
- Briassoulis, G., Ilia, S., & Briassouli, E. (2025). Exposure to Per- and Polyfluoroalkyl Substances (PFASs) in Healthcare: Environmental and Clinical Insights. Life. https://doi.org/10.3390/life15071057
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.